Description

(3-Oxo-2,3-Dihydro-Pyrido[3,2-B][1,4]Oxazin-4-Yl)-Acetic Acid is a high-purity heterocyclic building block and key synthetic intermediate of significant interest in advanced organic synthesis. This compound matters for its role as a versatile scaffold in the development of novel active pharmaceutical ingredients (APIs) and other fine chemicals. It is primarily needed by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical industries for drug discovery and process development programs.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and anti-infective therapies.
• Organic Synthesis Scaffold: Serves as a versatile precursor for constructing complex heterocyclic systems through further functionalization and ring-forming reactions.
• Agrochemical Research: Used in the research and development of new active ingredients for crop protection products.
• Ligand and Catalyst Development: Employed in the design and synthesis of novel ligands for metal catalysis and organocatalysts.
• Material Science Research: Investigated as a monomer or precursor for the development of advanced polymers and functional materials.
• Academic & Contract Research: Utilized in academic laboratories and CROs (Contract Research Organizations) for medicinal chemistry and synthetic methodology studies.

Basic Information

Product Name	(3-Oxo-2,3-Dihydro-Pyrido[3,2-B][1,4]Oxazin-4-Yl)-Acetic Acid
CAS No.	1018293-21-4
Molecular Formula	C9H8N2O4
Molecular Weight	208.17 g/mol
Synonyms	4-Carboxymethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one; 2H-Pyrido[3,2-b][1,4]oxazine-4-acetic acid, 3-oxo-; (3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-4-yl)acetic acid; 4-(Carboxymethyl)-3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine; 1018293-21-4; (3-Oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)acetic acid
EINECS	Contact for details

Quality Control

Our (3-Oxo-2,3-Dihydro-Pyrido[3,2-B][1,4]Oxazin-4-Yl)-Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all specifications and test results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This material is moisture-sensitive (hygroscopic); keep the container tightly sealed in a dry environment to prevent degradation. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.